AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: expert review
CL Bowlus, JK Lim, KD Lindor - Clinical Gastroenterology and Hepatology, 2019 - Elsevier
Description The purpose of this clinical practice update is to define key principles in the
surveillance of hepatobiliary cancers including cholangiocarcinoma, gallbladder …
surveillance of hepatobiliary cancers including cholangiocarcinoma, gallbladder …
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH,
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …
autoimmune hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; …
[HTML][HTML] Biomarkers and genetic markers of hepatocellular carcinoma and cholangiocarcinoma—what do we already know
J Baj, Ł Bryliński, F Woliński, M Granat, K Kostelecka… - Cancers, 2022 - mdpi.com
Simple Summary Hepatocellular carcinoma and cholangiocarcinoma continue to remain a
serious threat. In this review, we describe the most common biomarkers and genetic markers …
serious threat. In this review, we describe the most common biomarkers and genetic markers …
[HTML][HTML] Perioperative predictors of early recurrence for resectable and borderline-resectable pancreatic cancer
M Imamura, M Nagayama, D Kyuno, S Ota, T Murakami… - Cancers, 2021 - mdpi.com
Simple Summary Most patients with a pancreatic ductal adenocarcinoma develop a
recurrence after surgery. Predictive factors may therefore guide therapeutic decision …
recurrence after surgery. Predictive factors may therefore guide therapeutic decision …
[HTML][HTML] Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer
A Bittoni, F Pecci, G Mentrasti, S Crocetti… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background Pancreatic ductal adenocarcinoma (PDAC) detains a dismal prognosis and has
a limited number of prognostic factors. Inflammation has been demonstrated to play a key …
a limited number of prognostic factors. Inflammation has been demonstrated to play a key …
[HTML][HTML] Clinical applications of classical and novel biological markers of pancreatic cancer
L Pekarek, O Fraile-Martinez, C Garcia-Montero… - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic cancer is one of the most heterogeneous and aggressive
tumours that exist. The median survival of diagnosed patients is limited. For all these …
tumours that exist. The median survival of diagnosed patients is limited. For all these …
[HTML][HTML] Liquid biopsy approach to pancreatic cancer
S Perales, C Torres, C Jimenez-Luna… - World journal of …, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer (PC) continues to pose a major clinical challenge. There has been little
improvement in patient survival over the past few decades, and it is projected to become the …
improvement in patient survival over the past few decades, and it is projected to become the …
[HTML][HTML] Factors influencing blood tumor marker concentrations in the absence of neoplasia
J Trapé, E Fernández-Galán, JM Auge… - Tumor …, 2024 - content.iospress.com
BACKGROUND: Tumor markers (TMs) are a heterogeneous group of molecules used in the
diagnosis, prognosis and follow-up of cancer patients. During neoplastic differentiation, cells …
diagnosis, prognosis and follow-up of cancer patients. During neoplastic differentiation, cells …
[HTML][HTML] Biliary endoscopy in the management of primary sclerosing cholangitis and its complications
BM Fung, JH Tabibian - Liver research, 2019 - Elsevier
Primary sclerosing cholangitis (PSC) is a chronic, idiopathic, cholestatic liver disease
characterized by inflammation and fibrosis of the intrahepatic and/or extrahepatic bile ducts …
characterized by inflammation and fibrosis of the intrahepatic and/or extrahepatic bile ducts …
Defining an optimal surveillance strategy for patients following choledochal cyst resection: results of a systematic review
J Koea, M O'Grady, J Agraval… - ANZ Journal of …, 2022 - Wiley Online Library
Background Choledochal cysts should be treated with complete surgical resection, or, rarely
liver transplantation. Treated patients can remain at risk of developing metachronous …
liver transplantation. Treated patients can remain at risk of developing metachronous …